Showing results (321-330 of 331) with videos related to
Sort By:
Pageof 34
Cancer Research and Treatment|September 5, 2018
A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13Kwai Han Yoo, Su Jin Lee, Jinhyun Cho, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2022
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical TrialsSarah C Rutherford, Jun Yin, Levi Pederson, et al.Breast Cancer Research and Treatment|June 3, 2015
Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02)Yeon Hee Park, Kyung Hae Jung, Seock-Ah Im, et al.Nature Communications|February 6, 2026
Atypical protein kinase C activation drives intestinal glucose excretion in diabetes mellitusChan Woo Kang, Zhen-Yu Hong, Ju Hun Oh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04Jin Seok Ahn, Yong Chan Ahn, Joo-Hang Kim, et al.Transplantation and Cellular Therapy|January 23, 2022
Home-Based Hematopoietic Cell Transplantation in the United StatesAnthony D Sung, Vinay K Giri, Helen Tang, et al.Oncotarget|September 24, 2015
The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysisSeung Tae Kim, Jeeyun Lee, Mineui Hong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303Nancy L Bartlett, Wyndham H Wilson, Sin-Ho Jung, et al.Transplantation and Cellular Therapy|March 30, 2021
Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell TransplantationVinay K Giri, Kristin G Kegerreis, Yi Ren, et al.The Lancet. Oncology|February 14, 2016
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysisSeok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard, et al.Pageof 34